# Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis

> **NCT00385645** · PHASE4 · COMPLETED · sponsor: **Hospital Clinic of Barcelona** · enrollment: 255 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Combivir+Kaletra
- **DRUG:** Combivir+Reyataz

## Key facts

- **NCT ID:** NCT00385645
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2010-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385645, "Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00385645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*